You are currently viewing a new version of our website. To view the old version click .

Microbial Natural Products as a Source of Novel Antimicrobials

This special issue belongs to the section “Novel Antimicrobial Agents“.

Special Issue Information

Dear Colleagues,

Microbial natural products are molecules of significant interest in the development of novel antimicrobial agents.

Over the last decades, there have been reports of some microbial secondary metabolites, such as antimicrobial peptides, bacteriocins, and mycocins, with potential application in the food, agriculture, and pharmaceutical industries. However, few of them have been implemented as viable alternatives to the traditional antimicrobial agents, e.g., nisin and natamycin in food products.

Is crucial to fulfil the growing demand for more natural and eco-friendly biocides/preservatives applied in food products, crops, and cosmetics and to successfully achieve advancements in the development and implementation of novel less toxic, broad-spectrum antimicrobial agents.

Therefore, this Special Issue of Antibiotics seeks reviews, research papers, and short communications that can improve on the existing knowledge about microbial natural products with the potential to be an effective and less toxic alternative to the usual antibiotics, biocides, or chemical preservatives used nowadays. Thus, research related to the discovery of antimicrobial peptides, bacteriocins, and mycocins and their mode of action and application in food safety, food microbial control, agriculture, cosmetics, and human and animal health are welcomed.

Dr. Patricia Branco
Dr. Marc Maresca
Dr. Elisabete Muchagato Mauricio
Dr. Luisa Brito
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial peptides
  • mycocins
  • bacteriocins
  • antimicrobial activity
  • biopreservatives

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382